Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 13, 2024

Primary Completion Date

February 7, 2025

Study Completion Date

February 13, 2025

Conditions
Emergence DeliriumDelirium - Postoperative
Interventions
DRUG

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

"Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area.~After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room"

PROCEDURE

Nebulized 0.9% Normal Saline

Nebulization with normal saline 0.9% 3 ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room

Trial Locations (1)

Unknown

Anesthesiology and Intensive Therapy Udayana University, Denpasar

All Listed Sponsors
lead

Udayana University

OTHER

NCT06761092 - Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children | Biotech Hunter | Biotech Hunter